Tanaka A, Ishitsuka Y, Ohta H, Fujimoto A, Yasunaga JI, Matsuoka M.

Systematic clustering algorithm for chromatin accessibility data and its application to hematopoietic cells.

PLOS Comput Biol 16(11):e1008422. doi: 10.1371/journal.pcbi.1008422. eCollection 2020 Nov.

https://pubmed.ncbi.nlm.nih.gov/33253153/

Hashiguchi Y, Oda K, Katanoda T, Nosaka K, Jono H and Saito H

Clinical evaluation of cefotiam in the treatment of bacteremia caused by Escherichia coli, Klebsiella species, and Proteus mirabilis: A retrospective study.

J Infect Chemother 26(11):1158-1163. doi: 10.1016/j.jiac.2020.06.007. Epub 2020 Aug 20.

https://pubmed.ncbi.nlm.nih.gov/32828676/

Kondo Y, Suzuki K, Inoue Y, Sakata K, Takahashi C, Kaneko Y, Takeuchi T.

Safety and tolerability of ultrasound-guided synovial needle biopsy in Japanese arthritis patients.

Mod Rheumatol Online ahead of print. 20:1-9,2020. doi: 10.1080/14397595.2020.1847754.

https://pubmed.ncbi.nlm.nih.gov/33155872/

Kimura Y, Iwanaga E, Iwanaga K, Endo S, Inoue Y, Tokunaga K, Nagahata Y, Masuda K, Kawamoto H, Matsuoka M.

A regulatory element in the 3′-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.

Eur J Haematol. 2020 Nov 16.doi:10.1111/ejh.13551. PMID:33197296

https://pubmed.ncbi.nlm.nih.gov/33197296/

Imaizumi Y, Iwanaga M, Nosaka K, Ishitsuka K, Ishizawa K, Ito S, Amano M, Ishida T, Uike N, Utsunomiya A, Ohshima K, Tanaka J, Tokura Y, Tobinai K, Watanabe T, Uchimaru K and Tsukasaki K for collaborative Investigators.

Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.

Cancer Sci 111(12): 4567-4580. doi: 10.1111/cas.14658. Epub 2020 Oct 21.

https://pubmed.ncbi.nlm.nih.gov/32976684/

Yonekura K, Kusumoto S, Choi I, Nakano N, Ito A, Suehiro Y, Imaizumi Y, Yoshimitsu M, Nosaka K, Ohtsuka E, Hidaka M, Jo T. Sasaki H, Moriuchi Y, Ogata M, Tatetsu H, Ishitsuka K, Miyazaki Y, Ueda R, Utsunomiya A, Ishida T.

Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

Blood A dv 4(20):5133-5145,2020. doi: 10.1182/bloodadvances.2020003053.

https://pubmed.ncbi.nlm.nih.gov/33091125/

Yonekura K, Kusumoto S, Choi I, Nakano N, Ito A, Suehiro Y, Imaizumi Y, Yoshimitsu M, Nosaka K, Ohtsuka E, Hidaka M, Jo T. Sasaki H, Moriuchi Y, Ogata M, Tatetsu H, Ishitsuka K, Miyazaki Y, Ueda R, Utsunomiya A, Ishida T.

Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

Blood A dv 4(20):5133-5145,2020. doi: 10.1182/bloodadvances. 2020003053.

https://pubmed.ncbi.nlm.nih.gov/33091125/

Hosokawa K, Ishiyama K, Ikemoto T, Sugimori C, Noji H, Shichishima T, Obara N, Chiba S, Ninomiya H, Nguyen MAT, Shirasugi Y, Nakamura Y, Ando K, Ueda Y, Yonemura Y, Kawaguchi T, Nishimura J, Kanakura Y, Nakao S.

The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.

Ann Hematol Online ahead of print,2020. doi: 10.1007/s00277-020-04314-w

https://pubmed.ncbi.nlm.nih.gov/33095337/

Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CO, Tokunaga K,Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T.

Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.

Blood 136:1919-1932,2020. doi: 10.1182/blood.2019004292.

https://pubmed.ncbi.nlm.nih.gov/32573733/

Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CQ, Tokunaga K, Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T

Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.

Blood 136(17):1919-1932,2020. doi: 10.1182/blood.2019004292.

https://pubmed.ncbi.nlm.nih.gov/32573733/

Yanagawa Y, Shimogawara R, Endo T, Fukushima R, Gatanaga H, Hayasaka K, Kikuchi Y, Kobayashi T, Koga M, Koibuchi T, Miyagawa T, Nagata A, Nakata H, Oka S, Otsuka R, Sakai K, Shibuya M, Shingyochi H, Tsuchihashi E, Watanabe K, Yagita K.

Utility of the Rapid Antigen Detection Test E. histolytica Quik Chek for the Diagnosis of Entamoeba histolytica Infection in Nonendemic Situations.

J Clin Microbiol 58(11):e01991-20,2020. doi: 10.1128/JCM.01991-20. Print 2020 Oct 21.

https://pubmed.ncbi.nlm.nih.gov/32878955/

Kagami Y, Yamamoto K, Shibata T, Tobinai K, Imaizumi Y, Uchida T, Shimada K, Minauchi K, Fukuhara N, Kobayashi H, Yamauchi N, Tsujimura H, Hangaishi A, Tominaga R, Suehiro Y, Yoshida S, Inoue Y, Suzuki S, Tokuhira M, Kusumoto S, Kuroda J, Yakushijin Y, Takamatsu Y, KubotaY, Nosaka K, Morishima S, Nakamura S, Ogura M, Maruyama D, Hotta T, Morishima Y, Tsukasaki K, Nagai H.

R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma:JCOG0908 study.

Cancer Sci 111(10):3770-3779,2020. doi: 10.1111/cas.14604. Epub 2020 Sep 11.

https://pubmed.ncbi.nlm.nih.gov/32767806/

Oda K, Jono H, Nosaka K and Saito H.

Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.

Int J Antimicrob Agents 56: 106109,2020. doi: 10.1016/j.ijantimicag.2020.106109.

https://pubmed.ncbi.nlm.nih.gov/32721597/

Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K.

A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström’s macroglobulinemia.

Cancer Sci 111(9):3327-3337,2020. doi: 10.1111/cas.14561. Epub 2020 Jul 20.

https://pubmed.ncbi.nlm.nih.gov/32639651/

Shimoda K, Takahashi N, Kirito K, Iriyama N, Kawaguchi T, Kizaki M

JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN).

Int J Hematol 112 (3): 268-291,2020. doi: 10.1007/s12185-020-02964-0. Epub 2020 Aug 11.

https://pubmed.ncbi.nlm.nih.gov/32783166/

Okuma K, Kuramitsu M, Niwa T, Taniguchi T, Masaki Y, Ueda G, Matsumoto C, Sobata R, Sagara Y, Nakamura H, Satake M, Miura K, Fuchi N, Masuzaki H, Okayama A, Umeki K, Yamano Y, Sato T, Iwanaga M, Uchimaru K, Nakashima M, Utsunomiya A, Kubota R, Ishitsuka K, Hasegawa H, Sasaki D, Koh KR, Taki M, Nosaka K, Ogata M, Naruse I, Kaneko N, Okajima S, Tezuka K, Ikebe E, Matsuoka S, Itabashi K, Saito S, Watanabe T and Hamaguchi I

Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

Retrovirology 17(1):26, 2020. doi: 10.1186/s12977-020-00534-0.

https://pubmed.ncbi.nlm.nih.gov/32831150/

Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Sakai R, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, Yoshida S, Kojima M, Takahashi H, Tomita A, Atsuta Y, Maruyama D, Tanaka E, Suzuki T, Kinoshita T, Ogura M, Ueda R and Mizokami M.

Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma.

J Hepatol 73(2):285-293,2020.  doi: 10.1016/j.jhep.2020.03.009. Epub 2020 Mar 17.

https://pubmed.ncbi.nlm.nih.gov/32194183/

Utsunomiya M, Dobashi H, Odani T, Saito K, Yokogawa N, Nagasaka K, Takenaka K, Soejima M, Sugihara T, Hagiyama H,Hirata S, Matsui K, Nonomura Y, Kondo M, Suzuki F, Nawata Y, Tomita M, Kihara M, Yokoyama-Kokuryo W, Hirano F, Yamazaki H, Sakai R, Nanki T, Koike R, Miyasaka N, Harigai M.

An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.

Rheumatol Adv Pract 4(2):rkaa029,2020.  doi: 10.1093/rap/rkaa029. eCollection 2020

https://pubmed.ncbi.nlm.nih.gov/33134810/

Murata M, Yasunaga JI, Washizaki A, Seki Y, Kuramitsu M, Tan WK, Hu A, Okuma K, Hamaguchi I, Mizukami T, Matsuoka M, Araki H

Frequent horizontal and mother-to-child transmission may contribute to high prevalence of STLV-1 infection in Japanese macaques.

Retrovirology 17(1):15,2020. doi: 10.1186/s12977-020-00525-1.

https://pubmed.ncbi.nlm.nih.gov/32576215/

Higuchi Y, Yasunaga JI, Mitagami Y, Tsukamoto H, Nakashima K, Ohshima K, Matsuoka M.

HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling.

Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13740-13749. doi: 10.1073/pnas.1922884117. Epub 2020 May 29.

https://pubmed.ncbi.nlm.nih.gov/32471947/

Sakurai M, Okamoto S, Matsumura I, Murakami S, Takizawa M, Waki M, Hirano D, Watanabe-Nakaseko R, Kobayashi N, Iino M, Mitsui H, Ishikawa Y, Takahashi N, Kawaguchi T, Suzuki R, Yamamoto K, Kizaki M, Ohnishi K, Naoe T, Akashi K.

New Target investigators. Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line.

Int J Hematol 111 (6): 812-825,2020. doi: 10.1007/s12185-020-02843-8. Epub 2020 Mar 9.

https://pubmed.ncbi.nlm.nih.gov/32152876/

Makita S, Maruyama D, Maeshima AM, Taniguchi H, Yuda S, Toyoda K, Yamauchi N, Fukuhara S, Munakata W, Kobayashi Y, Kurihara H, Izutsu K and Tobinai K.

A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma.

Asia Pac J Clin Oncol 16(3):108-114,2020.  doi: 10.1111/ajco.13248. Epub 2019 Dec 4.

https://pubmed.ncbi.nlm.nih.gov/31802636/

Kuriyama H, Fukushima S, Nakahara S, Kanemaru H, Miyashita A, Aoi J, Tomita Y, Kawasaki T, Nosaka K and Ihn H.

Serious disseminated intravascular coagulation associated with combination therapy of nivolumab and ipilimumab in advanced melanoma.

J Dermatol 47(6):e235-e237,2020. doi: 10.1111/1346-8138.15336. Epub 2020 Apr 10.

https://pubmed.ncbi.nlm.nih.gov/32275077/